Health TrialsbyHealthPanel

Effect of Shock Wave Therapy on Myofascial Pain Syndrome in Adolescent Athletes

ConditionMyofascial Pain Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-18
SponsorCairo University

About this trial

The purpose of the study is to determine the effect of extracorporeal shockwave therapy on pain, neck range of motion, and functional activity in adolescent athletes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ranges from 14 to 18 years.

All adolescents have regional pain complaint.

Tenderness in cervical trigger points in the midpoint of the upper border of the trapezius muscle, from grade 2 to grade 4 according to the tenderness grading scheme (Hubbard, 1993) (Appendix II).

Palpation of a trigger point elicits a stereotypic zone of referred pain specific to that muscle.

Disqualifiers

Dermatological disorders.

Having myofascial trigger points injection.

Chronic pain in both sides of the body.

History of findings of cervical injury whether orthopedic or soft tissue injury.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Designed physical therapy program

    Other intervention

    Both groups will receive a designed physical therapy program, in the form of myofascial trigger points pressure release, stretching of the upper trapezius muscle, strengthening exercises, and infrared radiation for 4 weeks.

  • Extracorporeal shock wave therapy (ESWT)

    Other intervention

    Adolescents of the experimental group will receive Extracorporeal shock wave therapy with the following parameters; low-level energy radial extracorporeal shock wave by (STORZ MEDICAL Master Pulse MP200), each subject received 3 sessions per week for 4 weeks with 700 impulse/session 400 impulse was applied to tight band and 300 impulses will be applied surrounding the tight band, with frequency \[10HZ\], resulting in positive energy flux density \[EFD\] 0.056mJ/mm.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Designed physical therapy programActive comparator 1 intervention
Group B: Designed physical therapy program + Extracorporeal shock wave therapy (ESWT)Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Assessment of pain level

By Pain Quality Assessment Scale (PQAS), which help to measure different aspects of pain. For one patient, a pain might feel extremely hot and burning, but not at all dull, while another patient may not experience any burning pain, but feel like their pain is very dull and achy. High test-retest reliability has been observed in both literate and illiterate patients with neuropathic pain, for construct validity, was high in patients with chronic pain conditions. The scale creates a 20- item measures that would be even more useful for assessing neuropathic pain and also would be used to assess pain qualities associated with non-neuropathic pain. PQAS can be scored as individual ratings (20 items), or the PQAS items can be combined into composite scores.

Time frame
4 weeks

Secondary outcomes

1

Assessment cervical flexion range of motion (ROM)

It will be assessed by the CROM instrument pre and post-treatment. The subject should be seated upright in a straight-back chair with the sacrum against the backrest, thoracic spine away, arms at the sides, and feet flat on the floor. The CROM instrument is positioned like a pair of glasses and secured with Velcro straps. To ensure full cervical flexion, the movement begins with a slight nod to create a double chin (suboccipital flexion) before continuing into full flexion. The sagittal plane meter should be read through its beveled edge for an accurate magnified reading, and the measurement is recorded on the designated sheet.

Time frame
4 weeks
2

Assessment cervical extension range of motion (ROM)

It will be assessed by the CROM instrument pre and post-treatment. Cervical extension is measured by initiating a slight backward nod (suboccipital extension), followed by further extension until the full range is reached. The obtained measurement is then recorded accordingly.

Time frame
4 weeks
3

Assessment cervical lateral flexion ROM to the right

It will be assessed by the CROM instrument pre and post-treatment. To prevent rotation during lateral flexion, focus should remain on a fixed point straight ahead. A sagittal plane meter reading of zero confirms a neutral head position, while any deviation on the lateral flexion meter indicates lateral flexion at rest, which should be recorded. Lateral flexion of the head to the right is performed while maintaining level shoulders and avoiding rotation. Shoulder elevation is monitored and corrected manually if needed.

Time frame
4 weeks
4

Assessment cervical lateral flexion ROM to the left

It will be assessed by the CROM instrument pre and post-treatment. To prevent rotation during lateral flexion, focus should remain on a fixed point straight ahead. A sagittal plane meter reading of zero confirms a neutral head position, while any deviation on the lateral flexion meter indicates lateral flexion at rest, which should be recorded. Lateral flexion of the head to the left is performed while maintaining level shoulders and avoiding rotation. Shoulder elevation is monitored and corrected manually if needed.

Time frame
4 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: